Disease-Modifying Antirheumatic Drugs NewsLatest News On Disease-Modifying Antirheumatic Drugs Does Early Biologic Therapy Escalation Prevent Difficult-to-Treat Rheumatoid Arthritis?11/20/2024 3:11 AM Use of New DMARDs for Juvenile Idiopathic Arthritis Rose Steadily in Past 20 Years11/1/2024 6:14 AM Therapeutic Drug Monitoring in Rheumatology Has Potential but Faces a Host of Hurdles10/23/2024 8:23 AM JAK Inhibitors, Biologics Show Nuanced Differences in Rheumatoid Arthritis Pain Outcomes10/17/2024 3:18 AM Low Zoster Vaccination Rates in Immunocompromised Veterans10/11/2024 9:55 AM Coordinated Care Improves Anterior Uveitis in Children10/8/2024 6:29 AM Methotrexate May Prevent Rheumatoid Arthritis Development in Subset of ACPA–Negative Patients10/7/2024 7:22 AM Emapalumab Effective in Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis9/26/2024 1:46 AM Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse9/19/2024 8:30 AM Failed Remission Induction in Early Rheumatoid Arthritis No Better With Addition of Etanercept8/22/2024 10:50 PM Biologic Drugs May Mitigate Cardiovascular Event Risks in Patients With Rheumatoid Arthritis8/9/2024 12:54 AM Monoclonal Antibodies Make Promising Headway in Sjögren Disease Treatment8/5/2024 4:02 AM Multiple Investigational Approaches Show Promise for Treatment of Lupus8/1/2024 7:32 AM Considering a Taper for a Patient Receiving Opioid Therapy7/31/2024 2:06 PM Breaking Rheumatic Diseases' Reliance on Steroids: New Drug Candidates, Strategies7/25/2024 6:28 AM Factors Associated With Treatment Failure in Psoriatic Arthritis7/23/2024 7:57 AM Difficult-to-Treat Rheumatoid Arthritis Resolved in 45% Through Additional Treatment Changes7/4/2024 2:24 AM Biologic Agents Show Lower Psoriatic Arthritis Incidence Than Methotrexate in Psoriasis7/2/2024 11:34 PM Sonelokimab Yields Significant Improvements in Active PsA in Early Trial6/25/2024 11:42 PM TYK2 Inhibitor Shows Early Promise in Psoriatic Arthritis6/25/2024 3:25 AM
